KRO logo

KRO

Kronos Worldwide Inc

$4.67
-$0.20(-4.11%)
61
Overall
100
Value
50
Tech
34
Quality
Market Cap
$530.39M
Volume
647.45K
52W Range
$4.08 - $10.37
Target Price
$6.00

Company Overview

Mkt Cap$530.39MPrice$4.67
Volume647.45KChange-4.11%
P/E Ratio6.2Open$4.80
Revenue$1.9BPrev Close$4.87
Net Income$86.2M52W Range$4.08 - $10.37
Div Yield0.20%Target$6.00
Overall61Value100
Quality34Technical50

No chart data available

About Kronos Worldwide Inc

Kronos Worldwide, Inc. produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics and pharmaceuticals. It also produces ilmenite, a raw material used directly as a feedstock by sulfate-process TiO2 plants; iron-based chemicals, which are used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; specialty chemicals for use in the formulation of pearlescent pigments, and production of electroceramic capacitors for cell phones and other electronic devices, as well as for use in natural gas pipe, and other specialty applications. In addition, the company provides technical services for its products. It sells its products under the KRONOS brand through agents and distributors to paint, plastics, decorative laminate, and paper manufacturers. The company was founded in 1916 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc.

Sector: Basic Materials
Industry: Specialty Chemicals

Latest News

Akero Therapeutics Announces Merger and Delisting Plans

Akero Therapeutics ( ($AKRO) ) has provided an update. On December 9, 2025, Akero Therapeutics announced the consummation of a merger agreement tha...

TipRanks Auto-Generated Newsdesk8 days ago

Akero Therapeutics Shareholders Approve Novo Nordisk Merger

TipRanks Auto-Generated Newsdesk14 days ago

NVO,LLY: Shares Drop as Word Health Organization Calls for Cheaper Versions of Weight-Loss Drugs

David Craik16 days ago

Keros Therapeutics (KROS) Gets a Hold from Bank of America Securities

TipRanks Auto-Generated Intelligence Newsdesk19 days ago
ABCD
1SymbolPriceChangeVol
2KRO$4.67-4.1%647.45K
3
4
5
6

Get Kronos Worldwide Inc Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.